Literature DB >> 35104566

Factor analysis to determine relative contributions of strength, physical performance, body composition and muscle mass to disability and mobility disability outcomes in older men.

Jesse Zanker1, Terri Blackwell2, Sheena Patel2, Kate Duchowny3, Sharon Brennan-Olsen4, Steven R Cummings3, William J Evans5, Eric S Orwoll6, David Scott7, Sara Vogrin1, Gustavo Duque1, Peggy M Cawthon8.   

Abstract

BACKGROUND: It is not known how measures of body composition, strength and physical performance are interrelated or how empirical groupings of these measures relate to disability and mobility disability.
METHODS: Muscle mass was assessed by D3-creatine dilution (D3Cr muscle mass) in 1345 men (84.1 ± 4.1 years) enrolled in the Osteoporotic Fractures in Men (MrOS) study. Participants completed anthropomorphic measures, walk speed, grip strength, chair stands, and dual x-ray absorptiometry (DXA) estimated appendicular lean mass (ALM) and body fat percentage. Men reported limitations in mobility, activities of daily living (ADLs) and instrumental ADLs at initial and over 2.2 ± 0.3 years. Factor analysis reduced variables into related groups and negative binomial models calculated relative risk (RR) of factors with mobility and disability outcomes.
RESULTS: Factor analysis reduced 10 variables into four factors: Factor 1, body composition, including ALM, body fat percentage, weight and muscle mass; Factor 2, body size and lean mass, including height, weight and ALM; Factor 3, muscle mass, strength and performance, including walk speed, chair stands, grip strength, and muscle mass; and Factor 4, lean mass and weight, including ALM and weight. Only Factor 3 was significantly associated (p-value < .001) with prevalent disability (RR per standard deviation increment in factor score (reflecting higher muscle mass, strength and physical performance) 0.44, 0.35-0.56) and mobility disability (RR 0.22, 0.17 0.28), and incident mobility disability (RR 0.37, 0.27-0.50).
CONCLUSION: D3Cr muscle mass was the only body composition variable that co-segregated with strength and physical performance measures, and contributed to a factor that was associated with disability outcomes in older men.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Body composition; Muscle; Physical performance; Sarcopenia

Mesh:

Year:  2022        PMID: 35104566      PMCID: PMC8932551          DOI: 10.1016/j.exger.2022.111714

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  32 in total

1.  Lower extremity function and subsequent disability: consistency across studies, predictive models, and value of gait speed alone compared with the short physical performance battery.

Authors:  J M Guralnik; L Ferrucci; C F Pieper; S G Leveille; K S Markides; G V Ostir; S Studenski; L F Berkman; R B Wallace
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-04       Impact factor: 6.053

2.  Potential Medicare savings through prevention and risk reduction.

Authors:  Elizabeth Y Rula; James E Pope; Joel C Hoffman
Journal:  Popul Health Manag       Date:  2011-02       Impact factor: 2.459

3.  Clustering of strength, physical function, muscle, and adiposity characteristics and risk of disability in older adults.

Authors:  Peggy M Cawthon; Kathleen M Fox; Shravanthi R Gandra; Matthew J Delmonico; Chiun-Fang Chiou; Mary S Anthony; Paolo Caserotti; Stephen B Kritchevsky; Anne B Newman; Bret H Goodpaster; Suzanne Satterfield; Steven R Cummings; Tamara B Harris
Journal:  J Am Geriatr Soc       Date:  2011-05       Impact factor: 5.562

Review 4.  Adiposity, muscle mass, and muscle strength in relation to functional decline in older persons.

Authors:  Laura A Schaap; Annemarie Koster; Marjolein Visser
Journal:  Epidemiol Rev       Date:  2012-12-04       Impact factor: 6.222

5.  Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium.

Authors:  Shalender Bhasin; Thomas G Travison; Todd M Manini; Sheena Patel; Karol M Pencina; Roger A Fielding; Jay M Magaziner; Anne B Newman; Douglas P Kiel; Cyrus Cooper; Jack M Guralnik; Jane A Cauley; Hidenori Arai; Brian C Clark; Francesco Landi; Laura A Schaap; Suzette L Pereira; Daniel Rooks; Jean Woo; Linda J Woodhouse; Ellen Binder; Todd Brown; Michelle Shardell; Quian-Li Xue; Ralph B DʼAgostino; Denise Orwig; Greg Gorsicki; Rosaly Correa-De-Araujo; Peggy M Cawthon
Journal:  J Am Geriatr Soc       Date:  2020-03-09       Impact factor: 5.562

6.  Physical performance and risk of hip fractures in older men.

Authors:  Peggy Mannen Cawthon; Robin L Fullman; Lynn Marshall; Dawn C Mackey; Howard A Fink; Jane A Cauley; Steven R Cummings; Eric S Orwoll; Kristine E Ensrud
Journal:  J Bone Miner Res       Date:  2008-07       Impact factor: 6.741

Review 7.  Objectively measured physical capability levels and mortality: systematic review and meta-analysis.

Authors:  Rachel Cooper; Diana Kuh; Rebecca Hardy
Journal:  BMJ       Date:  2010-09-09

8.  Dilution of oral D3 -Creatine to measure creatine pool size and estimate skeletal muscle mass: development of a correction algorithm.

Authors:  Mahalakshmi Shankaran; Gregg Czerwieniec; Chancy Fessler; Po-Yin Anne Wong; Salena Killion; Scott M Turner; Marc K Hellerstein; William J Evans
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-04-16       Impact factor: 12.910

9.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

10.  Association of change in muscle mass assessed by D3 -creatine dilution with changes in grip strength and walking speed.

Authors:  Kate A Duchowny; Katherine E Peters; Steven R Cummings; Eric S Orwoll; Andrew R Hoffman; Kristine E Ensrud; Jane A Cauley; William J Evans; Peggy M Cawthon
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-10-17       Impact factor: 12.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.